Clinical trial · Observational
A Multicenter Prospective Study Evaluating the Diagnostic Performance of Femtosecond Laser Label-Free Imaging Combined With Artificial Intelligence for Predicting High-Risk Pathological Features in Lung Cancer
NCT07799038CI-TRIAL-00125264not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To investigate the diagnostic performance of Femtosecond Laser Label-Free Imaging combined with artificial intelligence for predicting high-risk pathological features in lung cancer
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer (Diagnosis) | Malignant Lung Neoplasm | CURATED_EXACT | 0.85 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Femtosecond Laser Label-Free Imaging Combined with Artificial Intelligence. | Diagnostic Test | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- The primary endpoint is the accuracy of the FLI combined with the AI model in predicting regional lymph node metastasis status in lung cancer, evaluated using postoperative pathology results as the reference standard.
- timeFrame
- through study completion, an average of 2 year
Eligibility
Eligibility (as posted)
- Sex
- All
Show eligibility criteria text
Inclusion Criteria: 1. Pulmonary nodules detected by clinical imaging with an indication for surgical resection. 2. Patient agrees to and is planned for pulmonary (partial) resection. 3. Resected specimens are suitable for FLI imaging. 4. Written informed consent obtained from the patient or legal representative. 5. Patients undergoing pulmonary (partial) resection at our hospital during this study. Exclusion Criteria: 1. Insufficient sample. 2. Specimen with crushing, contamination, or improper preservation, precluding valid imaging as judged by the investigator. 3. Inability to obtain matched pathology results corresponding to FLI images. 4. Inability to obtain final pathological diagnosis. 5. Other conditions deemed by the investigator as unsuitable for study participation.
References
Publications (0)
Data not yet available
No reference posted for this study.